Clin2
NCT07184606Worth exploringNot yet recruiting

Testing an investigational antibiotic infusion in healthy volunteers

Safety and Pharmacokinetics

This study tests a new experimental medicine called Fluorothiazinone, given as an infusion. It is one of the first steps in human testing to check the drug's safety and how the body processes it, so only healthy volunteers can participate.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
70 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are between 18 and 45 years old.
  • You are generally healthy with no chronic health conditions.
  • You have negative tests for HIV, hepatitis B/C, and syphilis.
  • You are not pregnant or breastfeeding and agree to use effective contraception.
  • You have not taken certain medications (like steroids or immunosuppressants) recently.
  • You have not participated in another clinical trial in the last 90 days.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07448155Recruiting· Phase 1
Testing a new drug in healthy volunteers

This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.

Tempe, Arizona
NCT07487545Not yet recruiting· Phase 1
Testing a single infusion of an investigational drug in healthy adults

This study tests a new investigational medicine called SSS67, given as a one-time IV infusion. It is an early-phase trial in healthy volunteers to check how safe the drug is and how the body handles it, and it may help researchers decide if it can be developed for future conditions.

Charlestown, New South Wales
NCT07500181Recruiting· Phase 1
Testing the safety of a new antibiotic in healthy adults

This trial tests an investigational antibiotic called BAL2420 to see if it is safe and how the body processes it. Healthy volunteers are needed to help determine the right dose before it can be studied in people with infections.

Groningen
NCT07526116Recruiting· Phase 1
Safety study of REGN22044 in healthy adults

This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.

Ghent, Oost-Vlaanderen
NCT07503405Not yet recruiting· Phase 2
Testing a new flu treatment in healthy adults

This study tests an experimental medicine called TRX-100 to see if it can safely treat the flu. Healthy volunteers will be given the flu virus in a controlled setting, then the medicine, to see how well it works.

London
NCT07829406Not yet recruiting· Phase 1
Safety study of a new medicine in healthy adults

This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.

Salt Lake City, Utah

Hear when a new Safety and Pharmacokinetics trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.